Intravenous immunoglobulin in livedo vasculitis: A new treatment option? [2]

Journal of the American Academy of Dermatology

Volumn 49, Issue 3, 2003, Pages 555-556

  Schanz, Stefan ^a   Ulmer, Anja ^a   Fierlbeck, Gerhard ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GLUCOCORTICOID; HEPARIN; IMMUNOGLOBULIN; PENTOXIFYLLINE;

ADULT; CASE REPORT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOTHERAPY; LETTER; PRIORITY JOURNAL; SEGMENTED HYALINIZING VASCULITIS; SKIN MANIFESTATION; SKIN ULCER; TREATMENT OUTCOME; VASCULITIS;

EID: 0042326318     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)00785-0     Document Type: Article

References (4)

1. Sabroe RA, Wallington TB, Kennedy CT. Dermatomyositis treated with high-dose intravenous immunoglobulins and associated with panniculitis. Clin Exp Dermatol 1995;20:164-7.
2. Dirschka T, Kastner U, Behrens S, Altmeyer P. Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin. J Am Acad Dermatol 1998;39:789-90.
3. Genereau T, Chosidow O, Danel C, Cherin P, Herson S. High-dose intravenous immunoglobulin in cutaneous lupus erythematosus. Arch Dermatol 1999;135:1124-5.
4. Amital H, Levy Y, Shoenfeld Y. Use of intravenous immunoglobulin in livedo vasculitis. Clin Exp Rheumatol 2000;18:404-6.